thedailyinvestor

Co Diagnostics Inc

Long
NASDAQ:CODX   Co-Diagnostics, Inc
Abnormal volume & undervalued
1 Year Price Target: $23.00 for a 180+/-% return

About: Co-Diagnostics, Inc. , a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.